Denis Drygin

Insider Reports History

Entity
Individual
Location
10628 Science Center Drive, Suite 225, San Diego, CA
Signature
Christopher Aker, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Denis Drygin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Chief Scientific Officer Common Stock 100K $119K $1.19 Mar 1, 2022 Direct
Regulus Therapeutics Inc. Chief Scientific Officer Stock Option (Right to Buy) 400K Jan 12, 2022 Direct

Insider Reports Filed by Denis Drygin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGLS Regulus Therapeutics Inc. Mar 1, 2022 1 $17.6K 4 Mar 1, 2022 Chief Scientific Officer
RGLS Regulus Therapeutics Inc. Feb 4, 2022 1 $5.36K 4 Feb 7, 2022 Chief Scientific Officer
RGLS Regulus Therapeutics Inc. Jan 12, 2022 1 $0 4 Jan 26, 2022 Chief Scientific Officer